Form 4: Lilly Endowment Sells Over 190,000 Shares of Eli Lilly Stock in Multiple Transactions

Lilly Endowment Inc. sold over 190,000 shares of Eli Lilly & Co. stock in a series of transactions on July 10, 2024, at prices ranging from $936.50 to $945.25.

Summary

• Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., executed multiple sales of common stock on July 10, 2024.
• The transactions involved the disposal of 197,910 shares of Eli Lilly stock.
• The sales were conducted at various weighted average prices, ranging from $936.895 to $944.899 per share.
• The total number of shares owned by Lilly Endowment Inc. after these transactions decreased to 96,943,810.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock sale by a major shareholder. It doesn't indicate any positive or negative sentiment about the company's performance or future prospects.

Industry Context

This filing reflects a significant transaction by a major shareholder of Eli Lilly & Co., which is common in the pharmaceutical industry. Such transactions can sometimes influence market sentiment and stock price.

Comparison to Industry Standards

• Large institutional investors like Lilly Endowment frequently adjust their holdings in publicly traded companies.
• These types of transactions are common and are often part of a broader portfolio management strategy.
• Other major pharmaceutical companies such as Pfizer and Johnson & Johnson also see similar filings from their large shareholders.

Stakeholder Impact

• The sale of shares by Lilly Endowment Inc. may have a minor impact on the stock price of Eli Lilly & Co.
• The transaction does not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Eli Lilly, Lilly Endowment, stock sale, shareholder, common stock, transaction, SEC Form 4